OpenResearchAlpha

Protein Science · 9 Nov 2026

A designer protein binder of KRAS enables exogenous protein degradation

Aniekan Okonh-index 6, Keith M. Cheah, Oscar J. Molina, Gabriel Saenz, K. Dane Wittrup, Ronald T. Rainesh-index 96

0
Citations
no database records one yet
0
Citations in 2026
so far
96
Leading author's h-index
Ronald T. Raines, in QAI's scholar index
50
References
works it cites, from open citation data

Citations by database

Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.

  • OpenCitations0
  • Crossref0

Citations per year

The current year is still counting.

  • 2026 so far0

Abstract

Abstract Targeted protein degradation has emerged as a powerful strategy for modulating intracellular proteins, particularly those lacking traditional small‐molecule binding pockets. While protein‐based degraders expand this approach to undruggable targets, they typically require intracellular expression in target cells, limiting their utility as exogenous research tools. Here, we engineer the Sso7d‐derived KRAS G12D binder R11.1.6 for use as a chemically conjugatable, exogenously deliverable degrader scaffold. We show that a C‐terminal arginine‐to‐cysteine variant can be produced in good yield and purity and conjugated to a von Hippel–Lindau (VHL) E3 ligase ligand, albeit with an approximately 10‐fold reduction in KRAS G12D affinity relative to parent R11. To reduce the number of lysines available for potential ubiquitination, we generate two lysine‐reduced variants—a fully lysine‐free variant (R11 ΔLys ) and a “lysine‐lite” variant retaining only the three lysines implicated in KRAS engagement (R11 Lite )—and demonstrate that both retain nanomolar affinity for wild‐type KRAS and KRAS G12D . Esterification of R11–VHL with an α‐aryl‐α‐diazoamide reagent enables cellular treatment with the chimeric conjugate and leads to VHL‐ligand‐dependent reduction in pan‐RAS levels in HPAF‐II cells, as shown by competition with excess free VHL ligand. Our results establish R11 variants as tractable protein‐engineering scaffolds for developing chemically conjugated biodegraders and provide design principles for engineering lysine‐reduced binders based on the Sso7d scaffold.

What the data shows

  • No database records a citation yet, as is usual for a paper this new.
  • Ronald T. Raines has the highest h-index among the authors (96).

Graph

This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.

Citing paper shares an authorAuthor without a profileSize shows citations, or h-index for authors

Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.

Start with

Authors (6)

Each author's standing in QAI's scholar index: the works their ORCID iD is attached to, and for anyone whose ORCID record names a lab OpenResearch follows, their arXiv preprints matched by name and a shared co-author. Names are as printed on the paper.

ProfileMost-cited paper

Cited by 0 papers

Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.

0 shown
No citing papers for this filter.

References (50)

What it cites, from open citation data, with Crossref's record of each.

Sign in to see 30 more references

A free account opens the rest of the citing papers and references on every paper’s page.